Related Experiment Video
Updated: Jul 8, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Synovial sarcoma: clinicopathologic features, treatment, and prognosis
Herrick J Siegel1, Wade Sessions, Mark A Casillas
1Department of Surgery, University of Alabama at Birmingham, 510 20th St South, Ste 920, 35294, USA.
Orthopedics
|January 18, 2008
Summary
Synovial sarcoma, a soft tissue tumor common in young individuals, often faces diagnostic delays due to subtle symptoms. Early detection and referral to orthopedic oncology specialists are crucial for optimal outcomes.
Area of Science:
- Orthopedic Oncology
- Soft Tissue Tumors
- Sarcoma Research
Background:
- Synovial sarcoma is a distinct soft tissue sarcoma subtype predominantly affecting young individuals.
- Delayed diagnosis is common due to insidious growth, varied imaging presentations, and symptoms mimicking trauma.
- Accurate diagnosis necessitates tissue sampling via needle or open biopsy.
Purpose of the Study:
- To highlight diagnostic challenges in synovial sarcoma.
- To emphasize the importance of biopsy technique and surgeon involvement.
- To discuss prognostic factors and future research directions.
Main Methods:
- Review of diagnostic procedures for synovial sarcoma.
- Analysis of prognostic indicators influencing patient outcomes.
- Discussion of current and future treatment strategies.
Main Results:
- Biopsy, particularly open biopsy, is essential for definitive diagnosis, especially for biphasic tumors.
- Tumor size (>5 cm), deep location, inadequate margins, and recurrence history are significant negative prognostic factors.
- Adjuvant therapies like radiation and chemotherapy may benefit high-risk patients.
Conclusions:
- Early suspicion and detection are vital for optimizing patient outcomes.
- Referral to an orthopedic oncology specialist before biopsy is recommended.
- Further multi-institutional studies are needed to clarify the role of adjuvant chemotherapy.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...